GLUCOSE ISOMERASE FROM IMMOBILIZED ARTHROBACTER GLOBIFORMIS
Glucose isomerase from immobilized Arthrobacter globiformis is a microbial enzyme preparation used in food processing to catalyze the reversible isomerization of sugars, most notably glucose to fructose, and is listed in the FDA’s Substances Added to Food inventory as an additive entry.
What It Is
Glucose isomerase from immobilized Arthrobacter globiformis is an enzyme preparation derived from cells or cellular material of the bacterium Arthrobacter globiformis that have been immobilized on or within a solid phase to facilitate repeated use in industrial processes. Enzymes such as glucose isomerase catalyze the reversible isomerization of aldose sugars to ketose sugars, a reaction of central importance in the production of sweeter sugar mixtures and in carbohydrate processing. In the context of food production, glucose isomerase is best known for its role in converting D‑glucose into D‑fructose, a reaction that underpins the industrial manufacture of fructose‑enriched syrups. Immobilization refers to the practice of fixing the enzyme to a solid matrix, which enhances its operational stability and reusability in continuous or repeated batch operations. Immobilized enzyme preparations allow food producers to maintain high catalytic activity while reducing enzyme loss and simplifying downstream separation steps. The specific preparation from Arthrobacter globiformis carries the CAS number 977090‑08‑6 and is one among several microbial sources of glucose isomerase utilized in industrial carbohydrate processing. Inclusion of this immobilized enzyme in food processing contexts targets technological functions rather than direct nutritional contributions. The enzymatic activity itself is a protein catalyst that facilitates a specific transformation rather than a nutritive ingredient.
How It Is Made
The manufacture of glucose isomerase from immobilized Arthrobacter globiformis begins with the cultivation of the bacterial strain under controlled fermentation conditions. In industrial settings, microbial fermentation is scaled to produce the enzyme in sufficient quantities; the cells or their extracts are then processed to enrich the enzyme activity. Following fermentation, the glucose isomerase enzyme is typically isolated or partially purified through steps such as filtration, centrifugation, and concentration of the culture broth to prepare the enzyme for immobilization. Immobilization itself can be achieved through a variety of well‑established techniques that fix the enzyme to or within a support material. These may include physical adsorption, covalent bonding to inert carriers, entrapment in polymeric gels, or encapsulation within porous solids. The choice of immobilization method is guided by considerations such as enzyme stability, activity retention, and suitability for the intended process conditions. Immobilized enzyme preparations are engineered to withstand repeated exposures to process fluids and to maintain catalytic function across multiple cycles of use. Once immobilized, the enzyme preparation is characterized for activity and stability and may be formulated or packaged for application in food processing operations where isomerization of sugars is required.
Why It Is Used In Food
Glucose isomerase preparations, including those from immobilized Arthrobacter globiformis, are used in food processing to catalyze the conversion of abundant, inexpensive sugars into forms that provide desirable functional attributes. The primary technological use of glucose isomerase in the food industry is in carbohydrate processing, where it facilitates the isomerization of glucose into fructose or other ketose sugars. Fructose is sweeter than glucose and has favorable solubility characteristics, making fructose‑enriched syrups valuable in the formulation of beverages, baked goods, confectionery, and other food products where sweetness and texture are key quality attributes. Enzymatic conversion using immobilized glucose isomerase allows manufacturers to carry out sugar transformation under milder conditions and with greater specificity than would be possible with non‑biological chemical methods. The enzyme’s catalytic action improves process efficiency and product consistency, and immobilization supports operational stability and reuse. While glucose isomerase itself is not a direct flavoring or nutritive ingredient, its application in sugar processing influences the final composition, sweetness, and functional performance of carbohydrate‑containing foods.
Adi Example Calculation
In illustrative examples for additives with established ADIs, regulatory agencies often show how a daily intake value might translate to real‑world consumption levels. For instance, if an enzyme had an ADI of X mg per kilogram of body weight, a person weighing 70 kilograms would have an illustrative tolerable intake of 70 times X mg per day. Because glucose isomerase from immobilized Arthrobacter globiformis does not have an identified numeric ADI in the available authoritative sources, no specific example calculation can be provided for this ingredient. This underscores that illustrative ADI calculations require a documented numeric ADI, which is not available for this preparation.
Safety And Health Research
Safety evaluations for enzyme preparations like glucose isomerase focus on the source organism, the purity of the preparation, and any residual components carried into food contact during processing. Regulatory inventories record the use of such enzymes, but detailed toxicological data specific to immobilized glucose isomerase from Arthrobacter globiformis are limited in publicly accessible evaluations. Enzyme preparations used in food processing are generally assessed for potential allergenicity, residual activity in final products, and the absence of harmful contaminants. The listing in FDA inventories reflects historical use and recognition of information relevant to safety and function, but it does not on its own constitute a risk assessment or numerical intake recommendation. Independent scientific committees such as JECFA evaluate enzyme preparations and other food additives based on available toxicology, exposure data, and analytical specifications. While glucose isomerase from certain microbial sources has been evaluated in JECFA monographs, no dedicated entry matched to the Arthrobacter globiformis immobilized preparation was located in the available database searches. In the absence of specific hazard data, enzyme preparations used under good manufacturing practices are typically regarded in terms of their intended technological function and minimal presence in finished food products, with the assumption that residual enzyme protein is denatured or removed during processing. This general safety context reflects broad regulatory experience with microbial enzymes but does not constitute a specific health claim for this particular preparation.
Regulatory Status Worldwide
In the United States, glucose isomerase from immobilized Arthrobacter globiformis is listed in the FDA’s Substances Added to Food inventory (formerly EAFUS) as an entry, indicating that it is recognized as a substance used in food processing contexts. Inclusion on the inventory reflects that information about its use has been recorded, but it does not by itself confirm an FDA additive approval or specific regulatory citation in the Code of Federal Regulations. As an entry in the Substances Added to Food inventory, manufacturers and regulators can trace historical use and context for the ingredient, although explicit conditions of use or limitations are not detailed in the inventory entry alone. Because specific sections of 21 CFR do not explicitly list this enzyme preparation under direct additive permissions, formal approval status is unclear and is reflected as null in the regulatory safety summary. At the international level, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) maintains a searchable database of evaluated food additives, including enzyme preparations, but no specific JECFA monograph for glucose isomerase from Arthrobacter globiformis could be identified with an explicit numeric ADI or evaluation summary in available records. Other glucose isomerase preparations from alternative microbial sources have established monographs within the FAO/WHO JECFA publications, but a direct match for the Arthrobacter globiformis immobilized preparation was not found in the available searches. This absence of a dedicated JECFA entry with explicit numerical safety values underscores the need for cautious interpretation of regulatory status in regions outside the United States and for enzyme preparations generally.
Taste And Functional Properties
As an enzyme preparation, glucose isomerase from immobilized Arthrobacter globiformis does not contribute a distinct taste when correctly removed or inactivated prior to final food formulation, since the protein catalytic agent itself is not a flavoring compound. Its functional value lies in the specific catalytic reaction it facilitates: the interconversion of glucose and other aldose sugars into fructose and related ketoses. The fructose produced by enzymatic isomerization exhibits a sweeter sensory profile compared to glucose, a property exploited in the formulation of syrups and sweeteners. Functionally, glucose isomerase preparations are designed to operate under process conditions optimized for activity, such as controlled pH and temperature ranges compatible with enzyme stability. Immobilized formats enhance the enzyme’s resistance to denaturation and permit stable performance over repeated use cycles. Enzymatic activity is dependent on the structural integrity of the protein and the presence of necessary cofactors in the reaction medium. Enzymes like glucose isomerase do not endure extreme heat or pH conditions indefinitely, and their activity diminishes when environmental parameters stray far outside optimal ranges. Nevertheless, when applied in food processing, immobilized glucose isomerase facilitates efficient conversion of sugars, enabling the production of sweeter or functionally tailored sugar syrups with minimal off‑flavors or by‑products common to harsh chemical transformations.
Acceptable Daily Intake Explained
An acceptable daily intake (ADI) represents an estimate of the amount of a food additive that can be consumed daily over a lifetime without an appreciable health risk, based on toxicological data and safety factors. ADIs are established by expert committees such as JECFA when sufficient data are available to model dose–response relationships and margins of exposure. In the case of enzyme preparations like glucose isomerase from immobilized Arthrobacter globiformis, no specific ADI value could be identified in authoritative databases, which reflects the limited nature of public safety evaluations for this particular preparation. For readers seeking to understand ADI values generally, it is important to note that they are not recommended consumption targets but rather safety thresholds derived from rigorous review of toxicology studies. When a numeric ADI is established for a substance, it is grounded in specific studies and regulator‑approved evaluations. In the absence of a documented ADI for this ingredient, regulatory inventories record its use and context, but no quantitative daily intake recommendation is available.
Comparison With Similar Additives
Glucose isomerase from immobilized Arthrobacter globiformis is one among several enzyme preparations used in carbohydrate processing. Other microbial sources of glucose isomerase include preparations derived from Streptomyces and Bacillus species, which have been historically evaluated in enzyme specification compendia and by expert committees. Compared to non‑enzymatic sweeteners such as high‑intensity sugar substitutes (e.g., aspartame or sucralose), glucose isomerase plays a distinct technological role in transforming sugar substrates rather than imparting sweetness directly. Within the class of microbial enzyme preparations, glucose isomerases share functional similarities in catalyzing sugar isomerization, but their operational characteristics, source organism properties, and immobilization matrices can vary. For regulatory purposes, enzyme preparations are often categorized by their functional class and source, and evaluations focus on purity, activity, and absence of harmful contaminants rather than direct nutritive impact. These comparisons highlight that enzyme preparations serve process‑oriented roles distinct from flavoring agents or nutritive additives, and their safety assessments are framed accordingly.
Common Food Applications Narrative
In modern carbohydrate processing, immobilized glucose isomerase preparations play a central role in shaping the composition of sweeteners that appear in a broad range of food products. The enzyme’s catalytic activity enables the conversion of glucose‑rich syrups into mixtures containing higher proportions of fructose, which is prized for its heightened sweetness relative to glucose. These fructose‑enriched syrups serve as ingredients in soft drinks, fruit‑flavored beverages, dairy desserts, baked foods, confectionery, and other processed foods where sweetness, mouthfeel, and stability are important quality attributes. Food manufacturers select enzymatic processing routes when seeking consistent, high‑yield transformation of sugars under milder conditions that preserve flavor integrity and minimize undesirable chemical by‑products. Immobilized glucose isomerase supports continuous or semi‑continuous operations in large‑scale production facilities, enabling processors to deliver carbohydrate bases tailored to specific applications. While the enzyme itself is a processing aid and not present at significant levels in finished food products, its functional contribution facilitates the production of sweetening ingredients that millions of consumers encounter daily in formulations ranging from breakfast syrups and fruit preparations to beverage systems and confectionery inclusions.
Safety & Regulations
FDA
- Notes: Not explicitly listed in 21 CFR additive approvals; listed in the FDA Substances Added to Food inventory without specific regulatory section confirmed.
EFSA
- Notes: EFSA evaluation specific to this enzyme preparation not identified.
JECFA
- Notes: JECFA evaluation specific to this *Arthrobacter globiformis* preparation not found in available authoritative sources.
Comments
Please login to leave a comment.
No comments yet. Be the first to share!